October 31, 2022 Thermo Fisher flashes the Covid cash The $2.6bn acquisition of The Binding Site is 2022’s biggest medtech deal, but investors are unmoved.
July 20, 2022 The other shoe finally drops for device dealmaking A combination of Covid and market gloom results in the fewest acquisitions closing for over 20 years.
January 20, 2022 Medical device groups float – then sink Medtechs rushed for the markets last year, but had an uneasy time once there.